- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips Set to Showcase AI-Based Solutions at Arab Health 2020
Company highlights CT, image-guided therapy, and enterprise imaging solutions.
DUBAI – Philips Healthcare is set to highlight several product offerings during the Arab Health 2020 annual meeting.
During the conference, the company will present its artificial intelligence (AI)-based solutions intended to improve patient care and care delivery. The overall goal, according to company information, is to develop integrated solutions that can adapt to customer needs and embed into individual workflows.
Over the next few days, conference attendees will have the opportunity review these Philips products:
- Azurion with FlexArm: This gantry development on Philips’ Azurion platform adds new imaging and patient positioning opportunities. It includes a set of innovations that facilitates performing 2D and 3D imaging across the whole patient.
- IQon Elite Spectral CT: As the industry’s only spectral detector-based CT system, it pairs conventional CT images with layers of spectral results in the same exam, potentially reducing the cost associated with repeat exams.
In addition, the company will showcase:
- Next-generation enterprise imaging informatics, including a suite of integrated products with a comprehensive platform designed to connect clinical capabilities and optimize workflows
- PerformanceBridge, Philips’ vendor-agnostic, integrated, scalable portfolio of analytics, services, and tools that gives hospital departments real-time information for performance improvement
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.
